调节编程细胞死亡的非编码RNA及其对癌症化学疗法耐药性的影响
Meijun Chen1, Peng Zhao1, Jinjiang Chou2
1State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine & Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education & Key Laboratory of Medical Molecular Biology of Guizhou Province, Guizhou Medical University, Guiyang 550014, China; Natural Products Research Center of Guizhou Province, Guiyang 550014, China; School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 561113, China.
International journal of biological macromolecules
|June 7, 2025
概括
非编码RNAs (ncRNAs) 调节癌细胞死亡,影响化疗耐药性. 针对这些ncRNA编程细胞死亡 (PCD) 途径提供了改善癌症治疗结果的新策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 非编码RNAs (ncRNAs),包括microRNAs (miRNAs),长非编码RNAs (lncRNAs),圆形RNAs (circRNAs),PIWI交互RNAs (piRNAs),tRNA衍生小RNAs (tsRNAs) 和小核RNAs (snoRNAs),是癌症的关键调节剂.
- 异常的ncRNA表达涉及到各种编程细胞死亡 (PCD) 途径,如亡,自,铁亡和热亡,影响癌症的进展和治疗反应.
研究的目的:
- 在化学抵抗的背景下,提供一个统一的框架,将六类ncRNA与四种PCD模式联系起来.
- 剖析ncRNAs调节PCD并影响各种癌症类型中药物耐药性的分子机制.
主要方法:
- 系统审查和分析涉及ncRNAs和PCD途径的分子电路.
- 检查ncRNA对酶激活,自流,脂质过氧化和炎症组合的影响.
主要成果:
- ncRNAs复杂地调节了亡,自,铁和热,从而塑造了瘤对化疗的反应.
- 已经确定了特定的ncRNA-PCD相互作用,这些相互作用是各种癌症类型的化学抵抗的基础.
结论:
- 准ncRNA编程细胞死亡 (PCD) 轴对克服化疗耐药性的治疗有希望.
- 解决交付和特异性挑战对于基于ncRNA的癌症疗法的临床转化至关重要.
相关概念视频
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Types of RNA
63.4K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.4K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K


